ICCU, San Giuseppe Moscati Hospital, ASL CE, Via Gramsci 1, Aversa 81031, Italy.
Department of Cardiology, Azienda Ospedaliera Bonomo, Viale Istria, Andria BT 76123, Italy.
Cardiol Clin. 2020 Nov;38(4):563-573. doi: 10.1016/j.ccl.2020.07.001. Epub 2020 Sep 17.
Primary percutaneous coronary intervention is the preferred reperfusion strategy for the management of acute ST-segment elevation myocardial infarction. No reflow is characterized by the inadequate myocardial perfusion of a given segment without angiographic evidence of persistent mechanical obstruction of epicardial vessels. Both pharmacologic and device-based strategies have been tested to resolve coronary no reflow. This article provides an updated overview of the no-reflow phenomenon, discussing clinical evidence and ongoing investigations of existing and novel therapeutic strategies to counteract it.
直接经皮冠状动脉介入治疗是急性 ST 段抬高型心肌梗死治疗的首选再灌注策略。无复流是指某一特定节段心肌的灌注不足,而无血管造影证据表明心外膜血管持续存在机械性阻塞。已经尝试了药物和器械策略来解决冠状动脉无复流。本文提供了无复流现象的最新综述,讨论了现有和新型治疗策略的临床证据和正在进行的研究,以对抗这种现象。